(Information sent by the signatory company)
Paris, December 13, 2022
Moon Surgical, a French-American pioneer in accessible surgical innovation, today announced the successful completion of 30 First-in-Human laparoscopy procedures using its Maestro System at CHU Saint-Pierre, a public teaching hospital in Brussels, Belgium.
Maestro is designed for surgeons and patients in the 18.8 million annual soft tissue surgeries not currently performed with telerobotic systems. The system is small, adaptable, and can be integrated into existing clinical workflows, while giving the surgeon greater control throughout the procedure. “I am delighted to be a part of this monumental achievement for Moon Surgical,” explained Prof. Guy-Bernard Cadière, former Chief of Surgery at CHU Saint-Pierre and legendary laparoscopic and robotic surgeon, who performed all 30 laparoscopic procedures with the Maestro System. “This technology is brilliant; it gave me more control throughout the entire procedure, keeping me confident and less fatigued at the end. Maestro is a huge asset to any surgeon, giving them the freedom to perform each procedure in the most effective way.” Maestro System’s goal is to increase the efficiency of operating rooms by improving existing surgical instruments and techniques while minimizing the impact on operating room turnover time. These attributes are especially valuable in high-volume procedures or in facilities focused on maintaining procedure volume. The 30 procedures were performed in 11 days and spanned seven different clinical indications. This demonstrated the adaptability of the Maestro System for use in various procedures and its minimal impact on operating room volume. In each of the procedures, with the help of the Maestro System, the surgeon did not need a surgical assistant to hold and manipulate the instruments. Fourteen of the completed procedures were laparoscopic cholecystectomies (removal of the gallbladder to treat gallstone disease symptomatic). In the United States, more than 700,000 cholecystectomies are performed each year, making it one of the most frequent surgical interventions in the world. Bariatric interventions, hernia repairs, colorectal surgeries, and gastric reflux surgeries were also performed.” This is another testimony how much the Maestro System can enhance the surgeon’s experience,” said Anne Osdoit, CEO of Moon Surgical and partner at MD Start, Sofinnova Partners’ medtech accelerator. “The results of our first human trial are a great validation of the value of the Maestro System in a real surgical setting. It is simply fantastic to see our system deliver treatments to patients. There is no greater reward than this.”About Moon Surgical Moon Surgical, based in Paris, France, and San Francisco, California, believes that the future of the operating room is in the hands of the skilled surgeon. By empowering surgeons with total control, renewed confidence, and technology that adapts to any situation that presented to them, Moon Surgical strives to improve the efficiency of operating rooms and provide better surgical care to patients. The minimalist, co-manipulative Maestro robotic system uses tomorrow’s technology to deliver these vital skills to surgeons, today. The company was founded in 2019 by Pr. Brice Gayet and incubated by Sofinnova MD Start. www.moonsurgical.com
Contact Contact name: Moon Surgical Contact description: Moon Surgical
